(Q48946840)

17 February 2018

title

Phospholipase A2 and the hypofrontality hypothesis of schizophrenia (English)

1 reference

17 February 2018

0 references

1 reference

W F Gattaz

1 reference

17 February 2018

J Brunner

series ordinal

1 reference

17 February 2018

publication date

1 August 1996

1 reference

17 February 2018

Prostaglandins, Leukotrienes and Essential Fatty Acids

published in

1 reference

17 February 2018

volume

1 reference

17 February 2018

issue

1-2

1 reference

17 February 2018

page(s)

109-113

1 reference

17 February 2018

Stimulation of Phospholipase A2and Secretion of Catecholamines from Brain Synaptosomes by Potassium and A23187

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Involvement of extracellular calcium and arachidonate in [3H] dopamine release from rat tuberoinfundibular neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Role of phospholipids in coupling of adenosine and dopamine receptors to striatal adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Effect of phospholipase digestion and lysophosphatidylcholine on dopamine receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Elevated PLA2 activity in schizophrenics and other psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Increased platelet membrane lysophosphatidylcholine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Behavioral and biochemical effects of intranigral injection of phospholipase-A2

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Correlation between left frontal phospholipids and Wisconsin Card Sort Test performance in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990154-4

7 January 2021

10.1016/S0952-3278(96)90154-4

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018